In recent years, the field of hepatology has undergone significant changes in both disease patterns and treatment strategies. While clinical practice previously focused primarily on managing advanced diseases, the current trend is towards early risk assessment, accurate damage evaluation, and individualized treatment from the outset. In this context, the Liver Summit 2026, organized by the … Continue reading Updating the latest developments in hepatobiliary diseases: From early risk identification to optimizing treatment